1. Home
  2. TCOM vs EW Comparison

TCOM vs EW Comparison

Compare TCOM & EW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TCOM

Trip.com Group Limited

HOLD

Current Price

$75.67

Market Cap

47.4B

ML Signal

HOLD

Logo Edwards Lifesciences Corporation

EW

Edwards Lifesciences Corporation

HOLD

Current Price

$85.23

Market Cap

49.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TCOM
EW
Founded
1999
1958
Country
Singapore
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.4B
49.5B
IPO Year
2003
2000

Fundamental Metrics

Financial Performance
Metric
TCOM
EW
Price
$75.67
$85.23
Analyst Decision
Strong Buy
Buy
Analyst Count
9
20
Target Price
$80.00
$96.11
AVG Volume (30 Days)
1.3M
3.0M
Earning Date
02-23-2026
02-10-2026
Dividend Yield
0.39%
N/A
EPS Growth
86.40
N/A
EPS
6.25
2.33
Revenue
$8,393,499,281.00
$5,883,800,000.00
Revenue This Year
$18.23
$14.29
Revenue Next Year
$13.78
$9.68
P/E Ratio
$12.29
$36.30
Revenue Growth
17.45
10.60
52 Week Low
$51.35
$65.94
52 Week High
$78.65
$87.89

Technical Indicators

Market Signals
Indicator
TCOM
EW
Relative Strength Index (RSI) 63.94 51.58
Support Level $75.75 $83.93
Resistance Level $77.65 $86.60
Average True Range (ATR) 1.07 1.38
MACD 0.43 -0.19
Stochastic Oscillator 71.86 44.58

Price Performance

Historical Comparison
TCOM
EW

About TCOM Trip.com Group Limited

Trip.com is the largest online travel agent in China and is positioned to benefit from the country's rising demand for higher-margin outbound travel as passport penetration is only 12% in China. The company generated about 79% of sales from accommodation reservations and transportation ticketing in 2024. The rest of revenue comes from package tours and corporate travel. Before the pandemic in 2019, the company generated 25% of revenue from international travel, which is important to its margin expansion. Most of sales come from its domestic platform, but the company is expanding its overseas business. The competes in a crowded OTA industry in China, including Meituan, Alibaba-backed Fliggy, Tongcheng, and Qunar. The company was founded in 1999 and listed on the Nasdaq in December 2003.

About EW Edwards Lifesciences Corporation

Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

Share on Social Networks: